Projects per year
Personal profile
Education/Academic qualification
Master
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
TB/NTM Cluster: TB/NTM Onderzoekscluster
de Jong, B., Sengstake, S., Rigouts, L., Tzfadia, O., Ardizzoni, E., Lynen, L., Decroo, T., Hasker, E., Van Rie, A., Lynen, L. & Hasker, E.
1/01/22 → 31/12/26
Project: Research Project
-
EndTB O5: EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilones
de Jong, B., Ardizzoni, E. & de Jong, B.
1/07/20 → 30/06/25
Project: Research Project
-
MSF Routine: MSF Routine Services
de Jong, B., Ardizzoni, E. & de Jong, B.
1/03/20 → 28/02/25
Project: Service
-
Effectiveness and tolerability of a short regimen for drug resistant tuberculosis treatment in Kandahar Province, Afghanistan, Uncontrolled Clinical Study
de Jong, B., Ardizzoni, E. & Janssens, N.
1/09/19 → 30/04/22
Project: Research Project
-
Treatment of Rifampin-resistsant Tuberculosis with an All-Oral Regimen containing new drugs in Zhytomyr Ukraine
de Jong, B., Ardizzoni, E. & Janssens, N.
1/03/19 → 31/07/21
Project: Research Project
Research output
-
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
Rupasinghe, P., Patil, S. B., Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M., Chavan, V., Cloez, S., Coit, J. M., Coutisson, S., Dakenova, Z., de Jong, B., & 33 others , 2023, In: Trials. 24, 1, 14 p., 773.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Improved diagnosis of drug-resistant tuberculosis : from implementation of simple phenotypic testing to whole genome sequencing
Ardizzoni, E., 2023, Antwerpen: Universiteit Antwerpen. 199 p.Research output: Thesis › Doctoral dissertation - Doctoral dissertation
Open Access -
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study
Huerga, H., Bastard, M., Lubega, AV., Akinyi, M., Antabak, NT., Ohler, L., Muyindike, W., Taremwa, IM., Stewart, R., Bossard, C., Nkosi, N., Ndlovu, Z., Hewison, C., Stavia, T., Okomo, G., Ogoro, JO., Ngozo, J., Mbatha, M., Aleny, C., Wanjala, S., & 9 others , 2023, In: Lancet Global Health. 11, 1, p. e126-e135 10 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Middlebrook 7H11 reduces invalid results and turnaround time of phenotypic drug susceptibility testing of M. tuberculosis
Rupasinghe, P., Vereecken, J., Decroo, T., Ardizzoni, E., Hewison, C., Huerga, H., Mesic, A., Rigouts, L. & de Jong, B., 2022.Research output: Contribution to conference › Poster
-
Middlebrook 7h11 reduces invalid results and turnaround time of phenotypic drug‑susceptibility testing of M. tuberculosis
Rupasinghe, R. A. P., Vereecken, J., Graulus, P., Decroo, T., Ardizzoni, E., Hewison, C., Donchuk, D., Huerga, H., Mesic, A., Rigouts, L. & de Jong, B., 2022, In: International Journal of Mycobacteriology. 11, 04, p. 407-411 5 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile69 Downloads (Pure)